C. Lafon, Athérosclérose : genèse, physiopathologie, Thèse de pharmacie, 2012.

J. Emmerich and . Maladie-des-vaisseaux, Collection intermed, pp.57-73, 1998.

H. Saarinen, C. Sittiwet, and P. Simonen, Determining the mechanisms of dietary turnip rapeseed oil on cholesterol metabolism in men with metabolic syndrome, Journal of Investigative Medicine
DOI : 10.1136/jim-2017-000495

F. Ahmed, A. El-kadiki, and S. J. Gibbons, Comparison of Lipoprotein Electrophoresis and Apolipoprotein E Genotyping in Investigating Dysbetalipoproteinemia, J Clin Lipidol, vol.17, pp.1933-2874, 2017.

M. Weiss, J. Berger, E. Gianos, and E. Fisher, Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention, Journal of Clinical Lipidology, vol.11, issue.5, pp.1933-2874, 2017.
DOI : 10.1016/j.jacl.2017.07.005

V. Sánchez, D. , A. Aguilar, C. , G. García et al., Advanced oxidation protein products and their relationship with cardiovascular risk factors in young apparently healthy people, Clin Investig Arterioscler, vol.17, pp.214-9168, 2017.

S. Murtada, J. Humphrey, and G. Holzapfel, Multiscale and Multiaxial Mechanics of Vascular Smooth Muscle, Biophysical Journal, vol.113, issue.3, pp.714-727, 2017.
DOI : 10.1016/j.bpj.2017.06.017

D. Lindholm, J. Lindbäck, and P. Armstrong, Biomarker-Based Risk Model to Predict??Cardiovascular Mortality in Patients??With??Stable??Coronary??Disease, Journal of the American College of Cardiology, vol.70, issue.7, pp.813-826, 2017.
DOI : 10.1016/j.jacc.2017.06.030

B. Stephan, S. Harrison, and H. Keage, Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia, Current Cardiology Reports, vol.149, issue.1, 2017.
DOI : 10.1016/j.physbeh.2015.05.035

G. Bories and N. Leitinger, Macrophage metabolism in atherosclerosis, FEBS Letters, vol.121, issue.184
DOI : 10.1161/CIRCRESAHA.116.310262

S. Bischetti, M. Scimeca, and E. Bonanno, Carotid plaque instability is not related to quantity but to elemental composition of calcification, Nutrition, Metabolism and Cardiovascular Diseases, vol.27, issue.9, pp.768-774
DOI : 10.1016/j.numecd.2017.05.006

F. Otsuka, K. Sakakura, and K. Yahagi, Has Our Understanding of Calcification in Human Coronary Atherosclerosis Progressed?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.34, issue.4, pp.724-760
DOI : 10.1161/ATVBAHA.113.302642

J. Michel, J. Martin-ventura, and A. Nicoletti, Pathology of human plaque vulnerability: Mechanisms and consequences of intraplaque haemorrhages, Atherosclerosis, vol.234, issue.2, pp.311-320
DOI : 10.1016/j.atherosclerosis.2014.03.020

T. Cate, H. Hackeng, T. García-de-frutos, and P. , Coagulation factor and protease pathways in thrombosis and cardiovascular disease, Thromb Haemost Jun, vol.28117, issue.7, pp.1265-1271, 2017.

T. Quillard, G. Franck, and T. Mawson, Mechanisms of erosion of atherosclerotic plaques, Current Opinion in Lipidology, vol.28, issue.5, pp.434-441
DOI : 10.1097/MOL.0000000000000440

C. Chen, Q. Li, and X. Nie, Association of lead exposure with cardiovascular risk factors and diseases in Chinese adults, Environmental Science and Pollution Research, vol.57, issue.28, pp.10-1007, 2017.
DOI : 10.1016/j.reprotox.2015.06.051

P. Nolan, G. Carrick-ranson, and J. Stinear, Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis, Preventive Medicine Reports, vol.7, pp.211-215, 2017.
DOI : 10.1016/j.pmedr.2017.07.004

J. Leigh, R. Kaplan, and K. Swett, Smoking intensity and duration is associated with cardiac structure and function: the ECHOcardiographic Study of Hispanics/Latinos, Open Heart, vol.4, issue.2, pp.614-624, 2017.
DOI : 10.1136/openhrt-2017-000614

J. Bodegard, J. Sundström, and B. Svennblad, Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: A cohort study of 8486 primary-care patients, Diabetes & Metabolism, vol.39, issue.4, pp.306-319, 2013.
DOI : 10.1016/j.diabet.2013.05.004

D. Sinning and U. Landmesser, Dyslipidemias : Diagnostics and management" Herz, pp.10-1007, 2017.

V. Triant and S. Grinspoon, Epidemiology of ischemic heart disease in HIV, Current Opinion in HIV and AIDS, vol.12, issue.6, 2017.
DOI : 10.1097/COH.0000000000000410

R. Janssen, A. Muller, and W. Simonides, Cardiac Thyroid Hormone Metabolism and Heart Failure, European Thyroid Journal, vol.6, issue.3, pp.130-137
DOI : 10.1371/journal.pone.0046655

URL : https://doi.org/10.1159/000469708

J. Vital, UE5 Organisation des appareils et systèmes: complément anatomique, 2011.

Z. H. Feng and J. G. Gong, Effects of dietary supplementation of resveratrol on performance, egg quality, yolk cholesterol and antioxidant enzyme activity of laying hens, British Poultry Science, vol.14, issue.5, pp.1-6, 2017.
DOI : 10.2460/ajvr.75.8.752

A. Fernández-quintela, I. Milton-laskibar, and M. González, Antiobesity effects of resveratrol: which tissues are involved?, Annals of the New York Academy of Sciences, vol.16, issue.1, 2017.
DOI : 10.1016/j.cmet.2012.09.015

D. Baudoux and M. L. Breda, Aromathérapie Scientifique, pp.4-8

D. Tr, M. F. , and M. Gv, Coronary heart disease in the Framingham study, Am J Public Health Nations Health, vol.47, pp.4-24, 1957.

M. Doyle and S. Bhimji, Statin Medications, 2017.

M. Elam, G. Majumdar, and K. Mozhui, Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge, PLOS ONE, vol.274, issue.52, 2017.
DOI : 10.1371/journal.pone.0181308.s006

P. Latry, M. Molimard, and B. Dedieu, Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study, BMC Cardiovascular Disorders, vol.47, issue.3, pp.46-56, 2011.
DOI : 10.1097/MLR.0b013e31818afa1c

URL : https://hal.archives-ouvertes.fr/inserm-00617198

R. Arbre, disponible sur https://www.ameli.fr/sites, 2017.

D. Elodie, Effets pléiotropes et perspectives thérapeutiques des statines dans le domaine cardiovasculaire, Thèse de pharmacie, 2012.

T. Jakob, A. Nordmann, and S. Schandelmaier, Fibrates for primary prevention of cardiovascular disease events, Cochrane Database Syst Rev, vol.21, issue.3, p.9753, 2016.
DOI : 10.1002/14651858.CD009753

A. Nordmann, I. Ferreira-gonzález, and B. Kasenda, Fibrates for primary prevention of cardiovascular disease events, Cochrane Database Syst Rev, vol.21, issue.1473-6535 (Elec, p.9753, 2016.
DOI : 10.1097/MOL.0b013e32833c1e74

H. Duckchoi and W. Gyoonshin, Safety and efficacy of fibrate?statin combination therapy compared to fibrate monotherapy in patients with dyslipidemia: A meta-analysis, Vascul Pharmacol, 2015.

O. Descamps, Les inhibiteurs de pcsk9 : une nouvelle classe d'hypolipémiants, p.2016

U. Landmesser, PCSK9 inhibition and clinical cardiovascular outcomes in patients with atherosclerotic cardiovascular disease, Cardiovascular Research, vol.113, issue.8, pp.24-25, 2017.
DOI : 10.1093/cvr/cvx109

. Boileau-c, Découverte d'un gène associé à l'hypercholestérolémie", unité INSERM 383 "Génétique chromosome et cancer, 2003.

A. Altowaijri, C. Phillips, and D. Fitzsimmons, A Systematic Review of the Clinical and Economic Effectiveness of Clinical Pharmacist Intervention in Secondary Prevention of Cardiovascular Disease, Journal of Managed Care Pharmacy, vol.19, issue.5, pp.408-424
DOI : 10.18553/jmcp.2013.19.5.408

N. Weiss, D. Waard, and M. , Les canaux calciques d??pendants du voltage au c??ur de la douleur, m??decine/sciences, vol.22, issue.4, pp.396-404, 2006.
DOI : 10.1051/medsci/2006224396

URL : http://www.medecinesciences.org/articles/medsci/pdf/2006/05/medsci2006224p396.pdf

C. Baigent, C. Sudlow, and R. Collins, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 2002.

J. Zhang, W. Liu, and T. Mccaffrey, Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease, Clinical Interventions in Aging, vol.12, pp.1271-1279, 2017.
DOI : 10.2147/CIA.S138592

G. Cui, S. Zhang, and J. Zou, P2Y12 receptor gene polymorphism and the risk of resistance to clopidogrel: A meta-analysis and review of the literature, Adv Clin Exp Med, 2017.

W. Hiatt, F. Fowkes, and G. Heizer, Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease, New England Journal of Medicine, vol.376, issue.1, pp.32-40, 2017.
DOI : 10.1056/NEJMoa1611688

M. Mazzeffi, K. Lee, and B. Taylor, inhibitors, Korean Journal of Anesthesiology, vol.70, issue.4, pp.379-389, 2017.
DOI : 10.4097/kjae.2017.70.4.379

P. Latry, K. Martin-latry, and M. Lafitte, Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database, EuroIntervention, vol.7, issue.12, pp.1413-1422
DOI : 10.4244/EIJV7I12A221

D. Raimondo, D. Tuttolomondo, A. Buttà, and C. , Antivitamin K Drugs in Stroke Prevention, Current Vascular Pharmacology, vol.11, issue.6, pp.817-840, 2013.
DOI : 10.2174/157016111106140128113404

F. Bajolle, M. Traore, and A. Grazioli, Observance et ??ducation th??rapeutique: l'exemple des antivitamines K (AVK) en cardiop??diatrie, Archives de P??diatrie, vol.22, issue.5, pp.15-21
DOI : 10.1016/S0929-693X(15)30009-9

R. Jurcu?, S. Militaru, and O. Geavlete, Predictive factors for obtaining a correct therapeutic range using antivitamin K anticoagulants: a tertiary center experience of patient adherence to anticoagulant therapy, Patient Preference and Adherence, vol.9, pp.1271-1279, 2015.
DOI : 10.2147/PPA.S87066

C. Blas-châtelain, S. Chauvelier, and P. Foti, Les d??terminants d???h??morragies graves des sujets ambulatoires ??g??s de 75ans et plus sous antivitamine K, Journal des Maladies Vasculaires, vol.39, issue.3, pp.169-77, 2014.
DOI : 10.1016/j.jmv.2014.02.003

S. Bornet and C. Dolapsakis, Direct oral anticoagulants : some practical considerations, Rev Med Suisse, vol.12, issue.529, pp.1453-1459, 2016.

G. Lippi, C. Mattiuzzi, and G. Cervellin, Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends, Annals of Translational Medicine, vol.5, issue.16
DOI : 10.21037/atm.2017.06.65

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566735/pdf

Y. Fujiwara, H. Ando, and K. Ushijima, Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats, Journal of Pharmacological Sciences, vol.134, issue.4
DOI : 10.1016/j.jphs.2017.08.001

F. Nardi, M. Gulizia, and F. Colivicchi, ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives, European Heart Journal Supplements, vol.19, issue.suppl_D, 2017.
DOI : 10.1093/eurheartj/sux007

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526472/pdf

M. Giustozzi, M. Verso, and G. Agnelli, Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence, Journal of Thrombosis and Thrombolysis, vol.64, issue.6, pp.10-1007, 2017.
DOI : 10.1111/j.1365-2125.2007.02899.x

M. Almegren, Reversal of direct oral anticoagulants Vasc Health Risk Manag, Jul, vol.13, pp.287-292, 2017.
DOI : 10.2147/vhrm.s138890

URL : https://doi.org/10.2147/vhrm.s138890

F. Dentali, S. Galliazzo, and F. Zuretti, Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?, Internal and Emergency Medicine, vol.9, issue.4, 2017.
DOI : 10.1007/s11739-014-1065-8

C. Lyon, A. Reed, and S. Prasad, PURLs: Direct oral anticoagulants or warfarin for A fib?, J Fam Pract, vol.66, issue.8, pp.518-519, 2017.

J. Bellon, Conseils à l'officine, aide au suivi pharmaceutique et à l'éducation thérapeutique du patient, pp.3-10, 2009.

D. Vital-durand, L. Jeune, and C. , Dorosz guide pratique des médicaments, Maloine édition 2017, pp.618-623

S. K?l?ç, E. ?im?ek, S. Kemal, and H. , The role of specialized prevention clinics for the short term follow-up of acute coronary syndromes, Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, vol.45, issue.6, pp.498-505, 2017.
DOI : 10.5543/tkda.2017.00400

. Angioplastie, disponible sur http://www.brusselsheartcenter.be/fr/cardiologie/examens-et-gestestherapeutiques/angioplastie .html 84Bioabsorbable stents -where are we now?" (internet) (cité le 19/09/2017) disponible sur http, 2017.

J. Emmerich and . Maladie-des-vaisseaux, Collection intermed, pp.113-114, 1998.